Skip to main content

Table 3 Plasma phospholipid EPA, DHA, and total n-3 FA levels (mean ± standard deviation, AUC [%*h], cmax [%] and tmax [t]) 72 h after ingestion of supplements

From: Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil

  

rTAG

EE

Krill oil

p*

 

EPA

37.05 ± 15.97

38.68 ± 18.60

53.62 ± 17.31

0.057

AUC [%*h]

DHA

22.73 ± 26.23

8.85 ± 22.57

26.41 ± 29.54

0.246

 

EPA+DHA

59.78 ± 36.75

47.53 ± 38.42

80.03 ± 34.71

0.119

 

total n-3 FA

66.35 ± 37.53

49.49 ± 46.88

88.40 ± 42.81

0.134

 

EPA

0.98 ± 0.26

0.79 ± 0.51

1.18 ± 0.45

0.095

cmax [%]

DHA

0.42 ± 0.48

0.21 ± 0.18

0.40 ± 0.41

0.323

 

EPA+DHA

1.12 ± 0.66

0.72 ± 0.76

1.51 ± 0.69

0.039

 

total n-3 FA

1.44 ± 1.06

0.73 ± 0.76

1.44 ± 0.89

0.110

 

EPA

11.5 ± 7.6

10.2 ± 8.6

7.8 ± 5.8

0.500

tmax [h]

DHA

5.0 ± 6.2

9.8 ± 20.6

4.2 ± 6.6

0.538

 

EPA+DHA

10.5 ± 10.2

9.0 ± 9.2

7.1 ± 6.0

0.649

 

total n-3 FA

16.2 ± 20.2

9.0 ± 9.2

8.0 ± 8.2

0.307

  1. Abbreviations: rTAG: re-esterified triacylglycerides; EE: ethyl esters; AUC: area under the curve
  2. * ANOVA